Cargando…
A pharmacogenetics study of platinum-based chemotherapy in lung cancer: ABCG2 polymorphism and its genetic interaction with SLC31A1 are associated with response and survival
Objective: The expression and function of platinum transporters affect drug tissue concentration and therapeutic effects. We had previously characterized functional variant of platinum intake transporter SLC31A1 gene. We aimed to investigate the association of platinum efflux transporter gene ABCG2...
Autores principales: | Wang, Liyan, Sun, Chang, Li, Xiangnan, Mao, Chenxue, Qian, Ji, Wang, Jiucun, Wu, Junjie, Li, Qiang, Bai, Chunxue, Han, Baohui, Gao, Zhiqiang, Xu, Jibin, Yin, Jiye, Liu, Zhaoqian, Lu, Daru, Jin, Li, Wang, Haijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847637/ https://www.ncbi.nlm.nih.gov/pubmed/33531973 http://dx.doi.org/10.7150/jca.51621 |
Ejemplares similares
-
Genetic polymorphism of SLC31A1 is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation
por: Sun, Chang, et al.
Publicado: (2018) -
Single nucleotide polymorphisms of nucleotide excision repair pathway are significantly associated with outcomes of platinum-based chemotherapy in lung cancer
por: Song, Xiao, et al.
Publicado: (2017) -
Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients
por: Zhao, Xueying, et al.
Publicado: (2015) -
Effect of Polymorphisms in XPD on Clinical Outcomes of Platinum-Based Chemotherapy for Chinese Non-Small Cell Lung Cancer Patients
por: Wu, Wenting, et al.
Publicado: (2012) -
Establishing a Prediction Model for the Efficacy of Platinum—Based Chemotherapy in NSCLC Based on a Two Cohorts GWAS Study
por: Xiao, Qi, et al.
Publicado: (2023)